Due to the fact that this first report is only a single post hoc analysis of a prior case-control genetic study, no conclusion can be made regarding any potential economic utility and clinical benefit that the MTNR1B rs10830963 genotyping would mean in a high-risk GDM population. This evidence concerns the gene MTNR1B and gestational diabetes.